rs587779715
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000090.4(COL3A1):c.3472G>C(p.Gly1158Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1158D) has been classified as Pathogenic.
Frequency
Consequence
NM_000090.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
- Ehlers-Danlos syndrome, vascular typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polymicrogyria with or without vascular-type Ehlers-Danlos syndromeInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
COL3A1-related disorder Pathogenic:1
The COL3A1 c.3472G>C variant is predicted to result in the amino acid substitution p.Gly1158Arg. This variant was reported in a study of individuals with vascular Ehlers-Danlos syndrome (EDS type IV) (Supplementary Table S1, Pepin et al. 2014. PubMed ID: 24922459). Of note, another variant impacting this same amino acid was also reported in the same study of individuals with vascular EDS [c.3473G>A (p.Gly1158Asp), Supplementary Table S1, Pepin et al. 2014. PubMed ID: 24922459]. The c.3472G>C variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. The majority of documented causative missense variants in COL3A1 substitute a glycine residue to another amino acid in the Gly-X-Y triple helical domain (Pepin et al. 2014. PubMed ID: 24922459). Taken together, we interpret this variant as likely pathogenic. -
Ehlers-Danlos syndrome, type 4 Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
PM1, PM2, PP1_mod, PS4_supp, PP2, PP3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at